Sustainability Edge Leverage the recent LEED Gold certification of Sartorius facilities, including the Ann Arbor site, to position offerings that support sustainable bioprocessing, energy and water efficiency, and green manufacturing capabilities for potential clients prioritizing ESG credentials.

Expansion Footprint Target conversations around Sartorius growth in Europe and Germany, highlighting new competence centers for cell and gene therapy components and expanded facilities, which may translate to enhanced regional service coverage, faster response times, and specialized testing and development support.

Acquisition Synergy Capitalizing on the BioOutsource and Cellca acquisitions to emphasize a broadened portfolio of process development and testing solutions, enabling cross-sell of bioprocess development, analytical testing, and cell line capabilities to biopharma customers.

Tech Integration Align with Sartorius’ digital and data-automation ecosystem (SAP CRM, Salesforce, Clarizen) to propose integrated workflows, digital quality management, and streamlined data capture from Cubis III balances and informatics systems for compliant, end-to-end lab operations.

Growth Opportunities Position Sartorius Stedim Biotech as a partner for bioprocessing scale-out and gene therapy support in Western Europe and North America, targeting mid to large biotech firms with a need for advanced testing, process development, and specialized components from new Freiburg and Freiburg-related competence centers.